Trial Profile

An Open-Label, Phase 2a Single Dose Study in Patients With Alcohol Use Disorder

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 04 Feb 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs 5 Methoxy N N Dimethyltryptamine (Primary)
Indications Alcoholism
Focus Adverse reactions
Sponsors Beckley Psytech

Most Recent Events

28 Jan 2025 According to Beckley Psytech media release, more detailed clinical data from this AUD study will be shared through publications and conferences in 2025.
28 Jan 2025 Results published in the Media Release
28 Jan 2025 Positive topline results presented in the ATAI Life Sciences media release Media Release.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com